Related Experiment Video
Updated: Aug 17, 2025

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Abnormal epicardial coronary vasomotor reactivity is associated with altered outcomes
Hélène Aélion1, Fabien Picard2, Arnaud Jégou3
1Cardiology Department, Cochin Hospital, AP-HP, 75014 Paris, France; Faculty of Medicine, University of Paris Cité, 75014 Paris, France.
Insights
Abnormal epicardial coronary vasomotor reactivity (ACVR) is common in patients with ischemic symptoms and normal coronary arteries. Provocative testing (PT) safely identifies patients at high risk for adverse cardiovascular events.
Area of Science:
- Cardiology
- Vascular Medicine
- Diagnostic Imaging
Background:
- Abnormal epicardial coronary vasomotor reactivity (ACVR) significance in patients with ischemic symptoms and non-obstructive coronary artery disease is unclear.
- Current diagnostic strategies involve provocative testing (PT) for patients with chest pain and no significant coronary stenosis.
Purpose of the Study:
- To evaluate the incidence, safety, and patient outcomes associated with using PT to diagnose ACVR.
- Assess the risk of major adverse cardiovascular and cerebrovascular events (MACCE) in patients with and without ACVR.
Main Methods:
- Retrospective observational study with a median 5-year clinical follow-up.
- Analysis of patients undergoing coronary angiography and subsequent PT.
- Primary outcome: incidence of ACVR. Secondary outcomes: MACCE (death, cardiovascular mortality, myocardial infarction, stroke, revascularization).
Main Results:
- ACVR was identified in 12.4% of patients undergoing PT.
- ACVR patients were more likely female, current smokers, and presented with suspected acute coronary syndrome.
- Patients with ACVR had a significantly higher incidence of MACCE, including myocardial infarction and coronary revascularization.
Conclusions:
- ACVR is a frequent finding in patients with ischemic symptoms and normal coronary arteries.
- Provocative testing (PT) is a safe and effective strategy for identifying patients with ACVR.
- Identifying ACVR highlights a population at increased risk for recurrent ischemic events.
Background:
The prevalence and significance of abnormal epicardial coronary vasomotor reactivity (ACVR) in patients with symptoms compatible with myocardial ischaemia remains ill-defined. Our diagnostic strategy is to perform a provocative test (PT) in every patient presenting with chest pain at rest, for whom coronary angiography does not reveal significant epicardial coronary artery disease (≥70% stenosis by visual assessment).
Aim:
To evaluate such a strategy in terms of incidence of ACVR, PT safety and patient outcomes.
Methods:
The present study was a retrospective observational study with a median clinical follow-up of 5years. The primary outcome was incidence of ACVR in patients with PT. Risk factors for ACVR and clinical follow-up were obtained, and the rate of major adverse cardiovascular and cerebrovascular events (MACCE; death, cardiovascular mortality, myocardial infarction, stroke and coronary revascularization) was reported.
Results:
ACVR was documented in 294 (12.4%) of the 2379 patients with PT, out of the 13,654 patients undergoing angiography. Patients with ACVR were more often female (43.9% vs. 30.0%; P<0.0001), current smokers (37.4% vs. 8.7%; P<0.0001) and had a suspected acute coronary syndrome (36.7% vs. 29.1%; P=0.005) at admittance compared with patients without ACVR. During clinical follow-up, MACCE occurred more frequently in patients with (9.8%) than in those without (3.7%) ACVR (hazard ratio [HR] 4.15, 95% confidence interval [CI] 2.62-6.57; P<0.0001), including more myocardial infarctions (4.0% vs. 0.4%; HR 17.8, 95% CI 6.41-49.5; P<0.0001) and more myocardial revascularizations (6.1% vs. 1.1%; HR 9.36, 95% CI 4.67-18.74; P<0.0001) compared with patients with normal PT at baseline.
Conclusions:
ACVR is frequent in patients with symptoms compatible with myocardial ischaemia at rest, with no significant coronary stenosis. PT is a safe strategy to identify a population at high risk of recurrent ischaemic events.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease III: Clinical Manifestations
Aortic Regurgitation III: Medical Management
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

